FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Naveed, Aiman [1 ]
Cheema, Huzaifa [1 ]
Shahid, Abia [1 ]
Singh, Harpreet [2 ]
Kurman, Jonathan [2 ]
Rehman, Mohammad Ebad Ur [3 ]
Umer, Mohammad [1 ]
Sahra, Syeda [4 ]
Ahmad, Faran [5 ]
Ahmad, Sharjeel [6 ]
机构：
[1] King Edward Med Univ, Lahore, Pakistan
[2] Med Coll Wisconsin, Milwaukee, WI USA
[3] Rawalpindi Med Univ, Rawalpindi, Pakistan
[4] Univ Oklahoma, Hlth Sci Ctr, Norman, OK USA
[5] Creighton Univ, Omaha, NE USA
[6] Univ Illinois, Coll Med, Dept Med, Infect Dis Sect, Peoria, IL USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
30
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials
    Fatemeh Movahed
    Ehsan Heidari
    Masoud Dehbozorgi
    Saba Goodarzi
    Fatemeh Esmaeilpur Abianeh
    Mohammad Abbasi
    Aida Rezaei Nejad
    Mohammad Javad Amini
    Mahmood Bakhtiyari
    Mojtaba Hedayat Yaghoubi
    Arman Shafiee
    Discover Medicine, 1 (1):
  • [22] REMDESIVIR FOR THE TREATMENT OF COVID-19: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Musa, Arif
    Warbasse, Elizabeth
    Yousif, Jenna
    Baron, David
    Stevens, Susan
    Blodget, Emily
    Pendi, Kasim
    Hashemi, Areio
    Aly, Besma
    Khambati, Alisha
    Tajran, Jahan
    Paradela, Danielle Rangel
    Chen, Daniel H.
    Kamal, Khalid
    Kouyoumjian, Sarkis
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S157 - S158
  • [23] Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Chia Siang Kow
    Long Chiau Ming
    Syed Shahzad Hasan
    Hypertension Research, 2021, 44 : 1042 - 1045
  • [24] A meta-analysis of randomized controlled trials of statin-based therapy in patients with COVID-19
    Kao, Guoying
    Chen, Yunlin
    Xiao, Jun
    Fan, Jinqi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (11) : 482 - 491
  • [25] Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
    de Moraes, Vinicius Ynoe
    Marra, Alexandre Rodrigues
    Matos, Leandro Luongo
    Serpa Neto, Ary
    Rizzo, Luiz Vicente
    Cendoroglo Neto, Miguel
    Lenza, Mario
    EINSTEIN-SAO PAULO, 2022, 20 : eRW0045
  • [26] Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials
    Singh, Avinash Kumar
    Vidyadhari, Arya
    Singh, Harmandeep
    Haider, Kashif
    Kumar, Anoop
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 16
  • [27] Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Vegivinti, Charan Thej Reddy
    Pederson, John M.
    Saravu, Kavitha
    Gupta, Nitin
    Barrett, Averi
    Davis, Amber R.
    Kallmes, Kevin M.
    Evanson, Kirk W.
    ANNALS OF MEDICINE AND SURGERY, 2021, 62 : 43 - 48
  • [28] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Muhammad Ehsan
    Uzair Jafar
    Momina Butt
    Aiman Naveed
    Mohammad Umer
    Muhammad Ayyan
    Biah Mustafa
    Rehmat Ullah Awan
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 495 - 498
  • [29] Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [30] Role of Thromboprophylaxis in Outpatients With COVID-19: A Meta-Analysis of Randomized Controlled Trials
    Singh, Sahib
    Tantry, Udaya
    Bliden, Kevin
    Garg, Aakash
    Gurbel, Paul
    CIRCULATION, 2023, 148
12345